1007-7669
2008 Issue 6
Determination of rat plasma protein binding rate of resveratrol derivative RT-B
LIU Yang;LIN Jian-yang;CHEN Xiao-hui;HAN Jing;BI Kai-shun
LIU Yang;LIN Jian-yang;CHEN Xiao-hui;HAN Jing;BI Kai-shun
..............page:403-406
Determination of mitiglinide in human plasma by LC-MS/MS and study of pharmacokinetics
SHI Xiao-peng;ZHAO Pei-xi;DING Li-kun;WU Yin;WANG Zhi-rui;JIA Yan-yan;YANG Zhi-fu;WEN Ai-dong
SHI Xiao-peng;ZHAO Pei-xi;DING Li-kun;WU Yin;WANG Zhi-rui;JIA Yan-yan;YANG Zhi-fu;WEN Ai-dong
..............page:407-411
Protective effect of Yulangsan flavones on myocardial ischemia reperfusion injury in rats
ZHANG Xu-dong;JIANG Wei-zhe;JIAO Yang;L(U) Ji-hua;WANG Nai-ping;HUANG Ren-bin
ZHANG Xu-dong;JIANG Wei-zhe;JIAO Yang;L(U) Ji-hua;WANG Nai-ping;HUANG Ren-bin
..............page:412-415
Effects of 2,3,4',5-tetrahydroxystilbene-2-O-β-D glucoside on expression of nitric oxide synthase and endothelium dependent vasodilation in artery vessels of experimental atherosclerotic rats
WANG Chun-hua;WANG Yu-qin;LI Feng;SHEN Yan;ZHANG Wei
WANG Chun-hua;WANG Yu-qin;LI Feng;SHEN Yan;ZHANG Wei
..............page:416-421
Bioequivalence of cloxacillin tablets and capsules in healthy volunteers
HE Li-en;ZHANG Shu-hui;SUN Ying-guang;MA Jie;QIU Zhi-hong
HE Li-en;ZHANG Shu-hui;SUN Ying-guang;MA Jie;QIU Zhi-hong
..............page:422-424
Protective effects of buflomedil on sciatic nerve crush lesion in rats
SU Jian-hua;ZHANG Li-ping;CHEN Yu-fang;TANG Jin-rong;XIAO Hang;BAO De-cheng
SU Jian-hua;ZHANG Li-ping;CHEN Yu-fang;TANG Jin-rong;XIAO Hang;BAO De-cheng
..............page:425-428
Pharmaeokinetics and bioequivalence of metoprolol sustained release tablets in Chinese healthy volunteers by LC-MS/MS
DONG Shu-ying;TONG Xu-hui;LI Jian-chun;WU Hua-pu;JIANG Zhi-wen
DONG Shu-ying;TONG Xu-hui;LI Jian-chun;WU Hua-pu;JIANG Zhi-wen
..............page:429-433
Clinical efficacy of cefminox for lower respiratory tract infection
PAN Bao-chang;PAN Xue;ZHOU Jia-ying
PAN Bao-chang;PAN Xue;ZHOU Jia-ying
..............page:434-436
Promoting safety of drug application by PASS and evaluation of PASS
SHAO Hua;LIU Nai-feng;CHEN Guo-ming;WU Bei-hua;QIAN Jing-xin;XU Ren-nan
SHAO Hua;LIU Nai-feng;CHEN Guo-ming;WU Bei-hua;QIAN Jing-xin;XU Ren-nan
..............page:437-441
Treatment advances in increasing high density lipoprotein
HUANG Zhen-hua
HUANG Zhen-hua
..............page:442-445
Connexin43:a new potential therapeutic target in restenosis
ZHU Ling-yu;JIANG Li-ping
ZHU Ling-yu;JIANG Li-ping
..............page:446-449
New advances of etanercept in treatment of psoriasis
YE Ting-lu;LU Chun
YE Ting-lu;LU Chun
..............page:450-453
Mitochondrial permeability transition pore and neurologic disease
ZHENG Chun-yan;ZHANG Hai-yan
ZHENG Chun-yan;ZHANG Hai-yan
..............page:454-461
xi bao du lei kang zhong liu yao wu fei lin chuang yan jiu ji shu zhi dao yuan ze
guo jia shi pin yao pin jian du guan li ju
guo jia shi pin yao pin jian du guan li ju
..............page:462-465
kang zhong liu yao wu lin chuang shi yan ji shu zhi dao yuan ze ( zheng qiu yi jian gao )
guo jia shi pin yao pin jian du guan li ju
guo jia shi pin yao pin jian du guan li ju
..............page:466-478
Anaphylaxis caused by combined use of metacaycline and Phellodendron amurense capsules in one patient
LI Ya-ling;WANG Chun-yu;LI Jun;QU Xiao-yan
LI Ya-ling;WANG Chun-yu;LI Jun;QU Xiao-yan
..............page:479-480
..............page:415